Forus

Healthcare · Artificial Intelligence

Funding

Forus raises $150M Series C, tripling valuation to $3B in months

The startup gives every prescription its own AI agent to cut through insurance and pharmacy delays for free.

• Forus raised $150 million in a Series C round led by Bain Capital Ventures, its seed-stage backer, valuing the company at $3 billion.
• Founded in 2023 by CEO Sahir Jaggi, Forus (formerly named Tandem) builds AI agents that connect doctors, pharmacies, payers and biopharma companies to speed up drug access.
• Every existing institutional investor reinvested, including Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures and SV Angel.
• The $3B valuation is roughly triple the roughly $1B level Forus reported around its May rebrand, and total funding now exceeds $300 million.
• More than a third of patients prescribed high-cost or complex medicines never receive their first dose, a gap Forus says its AI agents are built to close.
• Forus's platform is free for providers and patients, with commercial revenue instead coming from biopharma manufacturers seeking visibility into treatment access; it now works with 9 of the top 15 global biopharma companies and reaches providers in 85% of U.S. residential ZIP codes.
• The round underscores investor appetite for AI that automates healthcare's administrative back-office, a bottleneck long seen as separate from the clinical innovation it delays.